| 中文名 | 米卡芬净钠 |
|---|---|
| 英文名 | Pneumocandin A0, 1-[(4R,5R)-4,5-dihydroxy-N2-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]-, sodium salt (1:1) |
| 中文别名 |
米卡芬净纳 (MICAFUNGIN SODIUM) 博瑞批次
米卡芬净纳 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1- 羟基-3-氧丙基)-2,8,11,12,14,15,22,25-octahydroxy-6-((R)-1-羟乙基)-16-methyl-5,19-dioxo-9-( 4-(5-(4-(戊氧基)苯基)异恶唑-3-基)苯甲酰胺基)-2,3,5,6,9,10,11,12,14a,15,16,17,19,20, 23,25a-十六氢-1H-二吡咯并[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl) -2-羟基苯硫酸酯钠盐 MF/MK(国内GMP) 咪克芬净 米卡芬净纳 (MICAFUNGIN SODIUM) 米卡芬净,米卡芬净钠,咪克芬净 MICAFUNGIN SODIUM米卡芬净钠 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14AS,15S,16S,20S,23S,25AS)-20-((R)-3-AMINO-1- 羟基-3-氧丙基)-2,8,11,12,14,15,22,25-OCTAHYDROXY-6-((R)-1-羟乙基)-16-METHYL-5,19-DIOXO-9-( 4-(5-(4-(戊氧基)苯基)异恶唑-3-基)苯甲酰胺基)-2,3,5,6,9,10,11,12,14A,15,16,17,19,20, 23,25A-十六氢-1H-二吡咯并[2,1-C 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14AS,15S,16S,20S,23S,25AS)-20-((R)-3-AMINO-1- 羟基-3-氧丙基)-2,8,11,12,14,15,22,25-OCTAHYDROXY-6-((R)-1-羟乙基)-16-METHYL-5,19-DIOXO-9-( 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14AS,15S,16S,20S,23S,25AS)-20-((R)-3-AMINO-1- 羟基-3-氧丙基)-2,8,11,12,14,15,22,25-OCTAHYDROXY-6-((R)-1-羟乙基)-16-METHYL-5,19-DIOXO-9-( 4-(5-(4-(戊氧基)苯基)异恶唑-3-基)苯甲酰胺基)-2,3,5,6,9,10,11,12,14A,15,16,17,19,20, 23,25A-十六氢-1H-二吡咯并[ 米卡芬净钠 Micafungin Sodium 米卡芬钠盐 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14AS,15S,16S,20S,23S,25AS)-20-((R)-3-AMINO-1- 羟基-3-氧丙基)-2,8,11,12,14,15,22,25-OCTAHYDROXY-6-((R)-1-羟乙基)-16-METHYL-5,19-DIOXO-9-( 4-(5-(4-(戊氧基)苯基)异恶唑-3-基)苯甲酰胺基)-2,3,5,6,9,10,11,12,14A,15,16,17,19,20, 23,25A-十六氢-1H-二吡咯并[2,1-C:2',1'-L][1,4,7,10,13,16]HEXAAZACYCLOHENICOSI 米卡芬净钠/精确称量 氘11-米卡芬净钠盐 米卡芬净钠,10 MM DMSO 溶液 Micafungin Sodium 米卡芬净钠 米卡芬净钠盐 米卡芬净钠-[13C6]/精确称量 Anidulafungin (LY303366)阿尼芬净 Micafungin sodium 抑制剂 米卡芬静钠 |
| 英文别名 |
Micafungin Sodium Salt
FK 463; FUNGUD; MYCAMINE US-DMF No.: 031449 ASMF Approved Sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,8,11,12,14,15,22,25-octahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,19-dioxo-9-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzamido)-2,3,5,6,9,10,11,12,14a,15,16,17,19,20,23,25a-hexadecahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl)-2-hydroxyphenyl sulfate Micafungin sodium - Bio-X Sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,8,11,12,14,15,22,25-octahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,19-dioxo-9-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzamido)-2,3,5,6,9,10,11,12 FK463 Sodium Micafungin sodium //BP Micafungin sodium, 10 mM in DMSO Micafungin sodium Mycamine Sodium Micafungin (sodium) Fungud Micafungin Sodium (INTERNATIONAL COLD SHIPMENT REQUIRED) D11-Micafungin Sodium salt Micafungin sodium Mycamine micafungin sodium Impurity Micafungin-D11 Sodium salt 208-2 Micafungin sodium 1-[(4R,5R)-4,5-Dihydroxy-N2-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]pneuMocandin A0 MonosodiuM Salt sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5-(4-(pe Pneumocandin A0, 1-[(4R,5R)-4,5-dihydroxy-N2-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]-, sodium salt (1:1) Sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,8,11,12,14,15,22,25-octahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,19-dioxo-9-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzamido)-2,3,5,6,9,10,11,12,14a,15,16,17,19,20,23,25a-hexadecahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl)-2-hydroxyphenyl sulfate[FK 463 Sodium Micafungin sodium, >= Micafungin SodiuM(FK-463, MycaMine) Caffeine sodium Mycamine Micafungin SodiumQ: What is Micafungin Sodium Q: What is the CAS Number of Micafungin Sodium Q: What is the storage condition of Micafungin Sodium |
| 描述 | Micafungin sodium (FK 463) 是抗真菌剂,抑制1, 3-beta-D-glucan的合成。 |
|---|---|
| 相关类别 | |
| 体外研究 | 米卡芬净(10 mg/mL)在大多数分离株中表型减少了生物膜的形成。对于所有测试的基因,在米卡芬净处理的样品中mRNA转录水平也显着降低,参见。他们未经治疗的同行[1]。米卡芬净和KB425796-C的组合是杀真菌的并且显着减少了CFU的数量,与在每种药物单独使用时在所有检查的时间点观察到的真菌抑制作用(没有CFU减少)相反[2]。 |
| 体内研究 | 与施用盐水的小鼠相比,米卡芬净(1mg/kg)显着延长存活。给予米卡芬净(0.1mg/kg)和KB425796-C(32mg/kg)的组合的动物与仅用米卡芬净(0.1mg/kg)治疗的动物相比显示出延长存活的趋势。在米卡芬净治疗的小鼠的肝脏中,尽管清除效果低于肾脏中的清除效果,但CFU的数量减少。与在所有检查剂量下单独使用米卡芬净的治疗相比,使用米卡芬净和KB425796-C的组合治疗导致CFU数量的显着减少。 KB425796-C与米卡芬净组合的清除效应大于在AMPH处理的动物中观察到的清除效果[2]。 |
| 细胞实验 | 将每种真菌分离物在酵母 - 麦芽糖(YM)琼脂肉汤中静态温育24小时,温度为30℃。新生隐球菌YC203在YM肉汤培养基中于30℃在200rpm振荡下生长20小时。通过用无菌盐水洗涤培养的细胞一次来制备细胞悬浮液。将烟曲霉FP1305在马铃薯葡萄糖琼脂(PDA)斜面上培养4天,然后在无菌盐水中收获孢子并通过纱布过滤收集。除了C. neoformans之外,对所有分离株的抗真菌活性通过微量肉汤稀释法在96孔培养板中使用补充有1-谷氨酰胺但不含碳酸氢钠的RPMI 1640培养基测量,并用pH缓冲至pH 7.0。 0.165米MOPS。 FORC。使用新霉,酵母氮基 - 葡萄糖(YNBD)培养基。对于测定,将测试微生物接种到每个孔中以产生1×10 5 CFU /孔,然后将板在37℃下孵育20小时或48小时。通过显微镜观察确定两个终点:MEC,其定义为真菌生长的显着减少;和MIC,其定义为完全抑制生长。 |
| 动物实验 | 8组10只雌性DBA / 2小鼠(7周龄)静脉内注射2.0×106个烟曲霉FP1305孢子。试验组接受以下治疗:每天一次(qd)腹膜内(ip)给予1mg / kg体重/剂量的AMPH;米卡芬净以0.1,0.32或1mg / kg体重/剂量皮下给予(sc)(qd);米卡芬净给予sc(0.1,0.32或1mg / kgq.d。)加KB425796-C,每天两次给予ip(32mg / kg)(bid);和盐水(投标)。在第1天和第2天施用药物。在治疗完成后1天,每组中有5只小鼠被杀死。无菌取出肝脏和肾脏,然后将每个器官在5mL无菌盐水中匀浆。将匀浆的连续10倍稀释液涂布在PDA上并在37℃下孵育48小时,然后计算每克组织的CFU数。在攻击后每天检查每组剩余的5只小鼠的存活率,持续31天。 |
| 参考文献 |
| 分子式 | C56H70N9NaO23S |
|---|---|
| 分子量 | 1292.256 |
| 精确质量 | 1291.420288 |
| PSA | 518.52000 |
| 外观性状 | 粉末 |
| 储存条件 | -20℃ |